NasdaqGS:ZBIOBiotechs
Does Zenas BioPharma (ZBIO) CEO’s Million‑Dollar Share Buy Reframe Management Credibility After Recent Setbacks?
Zenas BioPharma recently disclosed that CEO Lonnie Moulder purchased over US$1,000,000 of company shares after earlier disappointment over Phase 3 INDIGO results for obexelimab in Immunoglobulin G4-Related Disease and the announcement of a securities investigation by Pomerantz LLP.
This combination of adverse clinical and legal headlines followed by a sizable insider buy has sharpened investor focus on management’s conviction and the future of Zenas’s autoimmune pipeline.
We’ll now examine...